Correlation Between VectivBio Holding and Capricor Therapeutics
Can any of the company-specific risk be diversified away by investing in both VectivBio Holding and Capricor Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VectivBio Holding and Capricor Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VectivBio Holding AG and Capricor Therapeutics, you can compare the effects of market volatilities on VectivBio Holding and Capricor Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VectivBio Holding with a short position of Capricor Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of VectivBio Holding and Capricor Therapeutics.
Diversification Opportunities for VectivBio Holding and Capricor Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between VectivBio and Capricor is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding VectivBio Holding AG and Capricor Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Capricor Therapeutics and VectivBio Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VectivBio Holding AG are associated (or correlated) with Capricor Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Capricor Therapeutics has no effect on the direction of VectivBio Holding i.e., VectivBio Holding and Capricor Therapeutics go up and down completely randomly.
Pair Corralation between VectivBio Holding and Capricor Therapeutics
Given the investment horizon of 90 days VectivBio Holding AG is expected to generate 0.74 times more return on investment than Capricor Therapeutics. However, VectivBio Holding AG is 1.35 times less risky than Capricor Therapeutics. It trades about 0.18 of its potential returns per unit of risk. Capricor Therapeutics is currently generating about 0.07 per unit of risk. If you would invest 776.00 in VectivBio Holding AG on October 21, 2024 and sell it today you would earn a total of 909.00 from holding VectivBio Holding AG or generate 117.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 22.78% |
| Values | Daily Returns |
VectivBio Holding AG vs. Capricor Therapeutics
Performance |
| Timeline |
| VectivBio Holding |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Capricor Therapeutics |
VectivBio Holding and Capricor Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with VectivBio Holding and Capricor Therapeutics
The main advantage of trading using opposite VectivBio Holding and Capricor Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VectivBio Holding position performs unexpectedly, Capricor Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Capricor Therapeutics will offset losses from the drop in Capricor Therapeutics' long position.| VectivBio Holding vs. Cns Pharmaceuticals | VectivBio Holding vs. ZyVersa Therapeutics | VectivBio Holding vs. Immix Biopharma | VectivBio Holding vs. Hepion Pharmaceuticals |
| Capricor Therapeutics vs. Bio Path Holdings | Capricor Therapeutics vs. NextCure | Capricor Therapeutics vs. Pulmatrix | Capricor Therapeutics vs. Akari Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |